Therapeutic implication of HER2 in advanced biliary tract cancer

Currently, there is no validated therapeutic target for biliary tract cancer (BTC). This study aimed to investigate the pre-clinical and clinical implication of HER2 as a therapeutic target in BTC. We established two novel HER2-amplified BTC cell lines, SNU-2670 and SNU-2773, from gallbladder cancer...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Nam, Ah-Rong, Kim, Ji-Won, Cha, Yongjun, Ha, Hyerim, Park, Ji Eun, Bang, Ju-Hee, Jin, Mei Hua, Lee, Kyung-Hun, Kim, Tae-Yong, Han, Sae-Won, Im, Seock-Ah, Kim, Tae-You, Oh, Do-Youn, Bang, Yung-Jue
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2016
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5295408/
https://ncbi.nlm.nih.gov/pubmed/27517322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11157
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items